These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31023224)

  • 1. Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.
    Frosini SM; Bond R; Rantala M; Grönthal T; Rankin SC; O'Shea K; Timofte D; Schmidt V; Lindsay J; Loeffler A
    BMC Microbiol; 2019 Apr; 19(1):81. PubMed ID: 31023224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
    Clark SM; Loeffler A; Bond R
    J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Chen HJ; Hung WC; Tseng SP; Tsai JC; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4985-91. PubMed ID: 20855746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of fusidic acid resistance in clinical isolates of Staphylococcus pseudintermedius from dogs in Korea.
    Lim YJ; Hyun JE; Hwang CY
    Vet Dermatol; 2020 Aug; 31(4):267-e62. PubMed ID: 32115810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.
    Lannergård J; Norström T; Hughes D
    Antimicrob Agents Chemother; 2009 May; 53(5):2059-65. PubMed ID: 19289529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.
    Castanheira M; Watters AA; Bell JM; Turnidge JD; Jones RN
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3614-7. PubMed ID: 20566766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusidic Acid Resistance Determinants in Methicillin-Resistant Staphylococcus aureus Isolated in Kuwait Hospitals.
    Boloki HA; Al-Musaileem WF; AlFouzan W; Verghese T; Udo EE
    Med Princ Pract; 2021; 30(6):542-549. PubMed ID: 34348297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions.
    Clark SM; Loeffler A; Schmidt VM; Chang YM; Wilson A; Timofte D; Bond R
    Vet Dermatol; 2016 Oct; 27(5):340-e84. PubMed ID: 27406860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation and Treatment of Fusidic Acid Resistance Among Methicillin-Resistant Staphylococcal Isolates from Egypt.
    Abouelfetouh A; Kassem M; Naguib M; El-Nakeeb M
    Microb Drug Resist; 2017 Jan; 23(1):8-17. PubMed ID: 27228193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
    Lim KT; Teh CS; Yusof MY; Thong KL
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of fusB in Staphylococcus aureus clinical isolates.
    Huang J; Ye M; Ding H; Guo Q; Ding B; Wang M
    J Med Microbiol; 2013 Aug; 62(Pt 8):1199-1203. PubMed ID: 23639984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of resistance to fusidic acid in staphylococci.
    O'Neill AJ; McLaws F; Kahlmeter G; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2007 May; 51(5):1737-40. PubMed ID: 17325218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fusidic acid resistance determinant, fusF, in Staphylococcus cohnii.
    Chen HJ; Hung WC; Lin YT; Tsai JC; Chiu HC; Hsueh PR; Teng LJ
    J Antimicrob Chemother; 2015 Feb; 70(2):416-9. PubMed ID: 25313205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and genetic characteristics of fusidic acid resistant Staphylococcus aureus clinical isolates: Emergence of t030 strains carrying fusB in Tehran, Iran.
    Goudarzi M; Seyedjavadi S; Bagheri P; Dadashi M; Nasiri MJ
    Acta Microbiol Immunol Hung; 2023 Jun; 70(2):126-133. PubMed ID: 36961740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
    J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital.
    Chen CM; Huang M; Chen HF; Ke SC; Li CR; Wang JH; Wu LT
    BMC Microbiol; 2011 May; 11():98. PubMed ID: 21569422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.